Gapping stocks in Monday's session
By Mill Chart
Last update: Apr 15, 2024
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Top Gap up stocks
| Ticker | Change | Comment |
|---|---|---|
| WISA | 9.0K% | WISA TECHNOLOGIES INC (NASDAQ:WISA) rose 9.0K% to $1.84 with a gap of 9.0K% during Monday's session. In the last month the share price dropped with 48.99%. |
| GRRR | 778.0% | During Monday's session, GORILLA TECHNOLOGY GROUP INC's (NASDAQ:GRRR) stock price showed a remarkable increase of 778.0%, reaching $5.27 with a notable 655.0% gap. Earlier today the company had a press release: Gorilla Technology Lanner Launch Cutting-Edge Security Convergence Devices to Transform Cybersecurity Landscape. |
| MRIN | 418.0% | MARIN SOFTWARE INC's (NASDAQ:MRIN) stock price is advancing with 418.0% to a price of $2.54 with a gap of 349.0%. In the last month the share price increased with 54.19%. |
| SNGX | 77.65% | During Monday's session, SOLIGENIX INC's (NASDAQ:SNGX) stock price showed a remarkable increase of 77.65%, reaching $0.69 with a notable 56.14% gap. In the last month the stock lost 39.37%. |
| LGVN | 55.09% | LONGEVERON INC-A's (NASDAQ:LGVN) shares soared 55.09% to $2.62 in Monday's session, displaying an impressive 9.63% gap. In the last month the stock lost 63.26%. |
| SPCB | 39.18% | During Monday's session, SUPERCOM LTD's (NASDAQ:SPCB) stock price showed an impressive increase of 39.18%, reaching $0.39 with a substantial gap of 9.74%. In the last month the stock gained 68.81%. |
| PLL | 29.73% | PIEDMONT LITHIUM INC's (NASDAQ:PLL) stock price is advancing with 29.73% to a price of $16.45 with a gap of 7.79%. Earlier today the company had a press release: Piedmont Lithium Receives Mining Permit Approval for Carolina Lithium. |
| ONVO | 29.7% | ORGANOVO HOLDINGS INC's (NASDAQ:ONVO) shares soared 29.7% to $1.31 in Monday's session, displaying an impressive 15.38% gap. The stock is trading 52.58% lower than a year ago. |
| MPW | 19.3% | During Monday's session, MEDICAL PROPERTIES TRUST INC's (NYSE:MPW) stock price showed a remarkable increase of 19.3%, reaching $4.76 with a notable 14.49% gap. Shareholders saw the stock price going 51.81% lower is the past year. |
| SES | 14.09% | During Monday's session, SES AI CORP's (NYSE:SES) stock price showed an impressive increase of 14.09%, reaching $1.7 with a substantial gap of 11.41%. In the last 6 months the share price dropped with 39.43%. |
For the full gap up stocks list go to our gap up stocks screener.
Today's top gap down stocks
| Ticker | Change | Comment |
|---|---|---|
| SAVAW | -85.18% | CASSAVA SCIENCES INC-28's (NASDAQ:SAVAW) shares experienced a 85.18% decline to $0.75 during Monday's session, accompanied by a 89.21% gap. Shareholders saw the stock price going 43.78% lower in the past 3 months. |
| MRNS | -77.46% | MARINUS PHARMACEUTICALS INC's (NASDAQ:MRNS) stock price is declining with 77.46% to a price of $1.7 with a gap of 79.35%. Earlier today the company had a press release: Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results. |
| KULR | -23.83% | KULR TECHNOLOGY GROUP INC's (NYSEARCA:KULR) shares fell 23.83% to $0.61 with a gap of 26.36%. In the last month the share price increased with 371.0%. |
| NXPL | -19.79% | NEXTPLAT CORP's (NASDAQ:NXPL) stock price is declining with 19.79% to a price of $1.5 with a gap of 44.03%. In the last month the share price increased with 35.51%. |
| CYN | -18.02% | In today's session, CYNGN INC's (NASDAQ:CYN) stock price decreased by 18.02% to $0.12, exhibiting a 26.06% gap. In the last 6 months the share price dropped with 57.75%. |
| VERU | -16.43% | Today, VERU INC's (NASDAQ:VERU) stock experienced a 16.43% fall to $1.27 with a 31.35% gap. In the last month the share price increased with 153.0%. |
| BHVN | -16.33% | During Monday's session, BIOHAVEN LTD's (NYSE:BHVN) stock price decreased by 16.33% to $44.41 with a significant 18.46% gap. In the last 6 months the share price increased with 95.58%. |
| BENF | -16.12% | BENEFICIENT - CLASS A's (NASDAQ:BENF) shares suffered a 16.12% decline to $0.08 during Monday's session, accompanied by a 35.02% gap. Shareholders saw the stock price going 28.16% higher in the past month. |
| VIRX | -15.65% | Today, VIRACTA THERAPEUTICS INC's (NASDAQ:VIRX) stock experienced a 15.65% fall to $0.97 with a 41.22% gap. In the last 3 months the share price increased with 93.8%. |
| RLYB | -15.45% | RALLYBIO CORP's (NASDAQ:RLYB) shares recorded a 15.45% decline to $1.86, with a notable 33.94% gap during today's session. The stock is trading 37.93% higher than a month ago. |
Our gap down stocks screener will show you the full list.
RALLYBIO CORP
NASDAQ:RLYB (5/8/2024, 3:01:07 PM)
After market: 1.9177 +0.07 (+3.66%)1.85
-0.07 (-3.65%)
RLYB News
a day ago - Rallybio CorporationRallybio to Present at the 2024 Citizens JMP Life Sciences Conference
21 days ago - Rallybio CorporationFNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting
a month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayFriday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning!
a month ago - Market News VideoThursday Sector Leaders: Drugs, Shipping Stocks
a month ago - InvestorPlaceWhy Is Hub Cyber Security (HUBC) Stock Down 7% Today?Hub Cyber Security stock is falling on Thursday after the company noted an investor sold a large stake of its HUBC shares.
a month ago - InvestorPlaceWhy Is Aptevo Therapeutics (APVO) Stock Down 56% Today?Aptevo Therapeutics stock is falling on Thursday after the company priced a public offering for 3.4 million shares of APVO.
a month ago - BusinessInsiderWhy Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving PremarketShares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.
